Key Takeaways:
- Medifast is set to report Q1 fiscal 2026 results on May 4.
- Forecasts predict a 36.3% year-over-year revenue decrease.
- The company is expected to post a loss of $0.55 per share.
Back
Back
Medifast to report Q1 results with revenue seen down 36%
Medifast Inc. (MED) is forecast to report a 36.3% year-over-year revenue decline for its first quarter on May 4, reflecting deep pressures on its coach-based business model and waning consumer demand.
The weight management company is projected to report a loss of $0.55 per share for the first quarter of fiscal 2026. This marks a sharp reversal from prior profitability, with the company citing challenges in retaining its network of independent coaches and attracting customers.
The negative forecast follows a period of struggle for the company, which competes with firms like WW International Inc. The core of the issue appears to be its multi-level marketing structure, where "coaches" sell diet plans to new clients. A shrinking coach base directly impacts sales and revenue generation.
A confirmation of the expected revenue drop and per-share loss could trigger a significant sell-off in Medifast's stock and may impact broader investor confidence in the weight management sector.
The projected results suggest Medifast's turnaround efforts have yet to gain traction. Investors will be closely watching the official announcement on May 4 for any new strategies to address the continued decline in its coach base and overall demand.
This article is for informational purposes only and does not constitute investment advice.
[1] Medifast's Q1 Earnings on The Horizon: Key Insights for Investors[2] Select Medical (SEM) Q1 2026 Earnings Transcript[3] Merit Medical outlines 2026 constant-currency revenue growth of 5.6% to 7% while integrating $140M View Point Medical deal[4] IRADIMED CORPORATION Reports First Quarter 2026 Financial Results[5] Reddit reports 69% jump in revenue, topping analyst estimates
